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Pulmonary alveolar proteinosis (PAP) is a rare and diffuse lung process, characterized by the presence of
alveolar spaces ﬁlled with amorphous eosinophilic material. Impaired macrophage function and
impaired host defence due to abnormalities of surfactant proteins may favor the growth of microor-
ganisms. The association of alveolar proteinosis with mycobacterial infections is rarely reported. The PAP
and superinfection with pulmonary tuberculosis is deﬁned by radiologic and histopathologic in a 46
year-old patient. The patients with PAP should be monitored for superinfection. It may cause the disease
progression and radiological, clinical symptoms may improve with treatment of superinfection.
Crown Copyright  2011 Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Pulmonary alveolar proteinosis (PAP) was ﬁrst described in 1958
by Rosen et al. and is a rare lung disease characterized by the
abnormal accumulation of PAS-positive (periodic acid-Schiff)
phospholipoprotein material in the alveoli.1 Two forms are
described: primary or idiopathic, which occurs in the absence
of another illness or a known environmental exposure; and
secondary, when associated with another morbid condition, espe-
cially infectious or neoplastic, in various states of immunosup-
pression, as well as in those resulting from the inhalation of
chemical agents and mineral particles (silica, aluminum, titanium,
and some insecticides). Several etiological agents have been iden-
tiﬁed in this population: Aspergillus sp.,Nocardia sp.,Mycobacterium
sp., Cryptococcus neoformans,Histoplasma capsulatum, Pneumocystis
carinii, and virus.2,3 The association of alveolar proteinosis and
pulmonary tuberculosis has been rarely reported. Educational aims
are the discussion of the radiologic, histopathologic and clinical
association of PAP and pulmonary tuberculosis in a case.2. Case report
A 46-year-old, life long non-smoker male was admitted to the
hospital with the complaints of dyspnea, cough and fever. He had
fatigue, non-productive cough and progressive dyspnea duringax: þ90 326 440 00 42.
ya).
evier Ltd. Open access under CC BY-NCtwo months and fever for a week. He is working as a welder. His
medical history was normal. Physical examination revealed the
bilateral ﬁne crackles. The purulent sputum was present. Chest
roentgenogram demonstrated the bilateral alveolar and interstitial
opacities with paracardiac non-homogenous opacity on right
hemithorax (Fig. 1A). The hemoglobin value was 10.1, peripheral
blood leukocyte count was 12,000 cell/cu mm and erythrocytes
sedimentation rate was 60 mm/h. Arterial blood gas values
during room-air breathing revealed that the pH: 7.52, pO2:
60 mmHg, pCO2: 24 mmHg and SaO2: 94%. Other laboratory values
were normal. Thorax CT revealed the bilateral ground-glass opac-
ities associated with thickened interlobular septa, called to as
“crazy paving” pattern (Fig. 2). Also, alveolar consolidation was
observed on right middle lobe. Fiberoptic bronchoscopy showed
the hyperemic bronchial mucosa. AFB-staining and cytological
examination of bronchial lavage ﬂuids were negative and benign,
respectively. Transbronchial biopsy was performed. Histopatho-
logic examination of transbronchial biopsy showed the alveolar
spaces ﬁlled with granular eosinophilic materials which were
Periodic acid-Schiff (PAS) positive (Fig. 3). The patient wanted to
get discharged on 2nd day of hospitalization and he did not want
to receive any treatment. Ten days later, he was admitted to the
hospital with fever. Chest radiograph on second admission was
similar to the ﬁrst admission. The direct smear of the sputum
showed acid-fast bacilli with AFB-staining. The culture of previ-
ously taken bronchial lavage ﬂuid grew Mycobacterium tubercu-
losis. Antituberculosis treatment combined with regimen of
isoniazid, morfozinamid, rifampicin and ethambutol was started.
The symptomatic and radiologic improvements were observed
after the treatment (Figs. 1A and 4).-ND license.
Fig. 1. Chest roentgenogram is showing the bilateral alveolar, interstitial opacities with paracardiac non-homogenous opacity on right hemithorax (1A) and regression is seen after
six months later with antituberculous therapy (1B).
S. Tekgül et al. / Respiratory Medicine Case Reports 5 (2012) 25e28263. Discussion
Pulmonary alveolar proteinosis (PAP) is a rare and diffuse lung
process, etiology undetermined, characterized by the presence of
alveolar spaces ﬁlled with amorphous eosinophilic material.1,4 The
accumulation in alveolar spaces is probably caused by defectiveFig. 2. Thorax CT scans are showing the bilateral ground-glass opacities associaclearance of lipoproteinaceous material by alveolar macrophages.
Recent animal experiments have suggested that GM-CSF (gran-
ulocyte-macrophage colony stimulating factor) deﬁciency might
play a role in the pathogenesis.5,6
Secondary PAP could be associated with 3 main clinical settings:
Infection of the lung, most commonly with Norcardia astroides, TB,ted with thickened interlobular septa, called to as “crazy paving” pattern.
Fig. 3. Histopathologic examination of transbronchial biopsy is showing the alveolar spaces ﬁlled with granular eosinophilic materials which were Periodic acid-Schiff (PAS)
positive.
Fig. 4. The radiologic improvements are showing on thorax CT scans after the six months with antituberculous treatment.
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malignancies and other conditions that alter the patient’s immune
status, e.g., lymphoma, leukemia, or AIDS. And exposure to inhaled
chemicals and minerals, e.g., fumes, dusts, silica, aluminum,
insecticides, or titanium leading to type II pneumocyte destruc-
tion.7,8 The material ﬁlling alveolar spaces in secondary PAP is
mainly cell debris and ﬁbrin.9 Bilateral air space consolidation is
a typical but non-speciﬁc feature appearing on chest radiography.
High resolution computed tomography scanning (HRCT) reveals
ground-glass opaciﬁcation usually associated with thickened
interlobular septa, distinctly visible within the affected lung,
referred to as “crazy paving” pattern and under the light micros-
copy the alveoli and terminal bronchioles are ﬁlled with a granular
lipoproteinaceousmaterial which stains a deep pink with PAS stain,
as seen in our patients. A major and typical complication of PAP is
infection with Nocardia species, Mycobacterium species, C. neofor-
mans, H. capsulatum, P. carinii and viruses. This susceptibility to
unusual organism is multifactorial. Impaired macrophage function
and impaired host defence due to abnormalities of surfactant
proteins may favor the growth of microorganisms. The association
of alveolar proteinosis with mycobacterial infections is rarely
reported. This association may not be fortutious and they usually
described with M. tuberculosis infection was superimposed on the
pulmonary alveolar proteinosis, which acted a predisposing factor.
Very few cases were deﬁned with pulmonary tuberculosis accom-
panied to PAP. Two of them as superinfection of the proteinosis in
the adult patients with acquired immune deﬁciency syndrome, one
case in a HIV positive infected child and one with the association
proteinosis and diabetes mellitus.2e4,9,10We think that the M. tuberculosis was evolved as a superinfec-
tion on PAP. Because of the crazy pattern seen bilaterally in our
patient. If the PAPwere secondary to tuberculosis, the crazy pattern
would be expected as localized.
In conclusion; superinfection ofM. tuberculosismay raise risk for
patients with PAP. The patients with PAP should be monitored for
superinfection. Itmay cause the disease progression and radiological,
clinical symptoms may improve with treatment of superinfection.References
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